303 related articles for article (PubMed ID: 38256140)
21. Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model.
Andreou T; Williams J; Brownlie RJ; Salmond RJ; Watson E; Shaw G; Melcher A; Wurdak H; Short SC; Lorger M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707311
[TBL] [Abstract][Full Text] [Related]
22. Structural studies of the TGF-βs and their receptors - insights into evolution of the TGF-β superfamily.
Hinck AP
FEBS Lett; 2012 Jul; 586(14):1860-70. PubMed ID: 22651914
[TBL] [Abstract][Full Text] [Related]
23. Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.
Esaki S; Nigim F; Moon E; Luk S; Kiyokawa J; Curry W; Cahill DP; Chi AS; Iafrate AJ; Martuza RL; Rabkin SD; Wakimoto H
Int J Cancer; 2017 Dec; 141(11):2348-2358. PubMed ID: 28801914
[TBL] [Abstract][Full Text] [Related]
24. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
[TBL] [Abstract][Full Text] [Related]
25. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
[TBL] [Abstract][Full Text] [Related]
26. Bone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years.
Ehata S; Miyazono K
Front Cell Dev Biol; 2022; 10():883523. PubMed ID: 35693928
[TBL] [Abstract][Full Text] [Related]
27. A tumor-promoting role for soluble TβRIII in glioblastoma.
Burghardt I; Schroeder JJ; Weiss T; Gramatzki D; Weller M
Mol Cell Biochem; 2021 Aug; 476(8):2963-2973. PubMed ID: 33772427
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-β mimics the key proteome properties of CD133
Bryukhovetskiy I; Shevchenko V; Arnotskaya N; Kushnir T; Pak O; Victor Z; Zaitsev S; Khotimchenko Y; Bryukhovetskiy A; Sharma A; Sharma HS
Int Rev Neurobiol; 2020; 151():219-242. PubMed ID: 32448609
[TBL] [Abstract][Full Text] [Related]
29. Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition.
Krishnan S; Szabo E; Burghardt I; Frei K; Tabatabai G; Weller M
Oncotarget; 2015 Sep; 6(26):22480-95. PubMed ID: 26090865
[TBL] [Abstract][Full Text] [Related]
30. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.
Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H
Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483
[TBL] [Abstract][Full Text] [Related]
31. mRNA expression of type I and type II receptors for activin, transforming growth factor-beta, and bone morphogenetic protein in the murine erythroleukemic cell line, F5-5.fl.
Machida H; Ogawa K; Funaba M; Mizutani T; Tsujimoto M
Eur J Endocrinol; 2000 Nov; 143(5):705-10. PubMed ID: 11078996
[TBL] [Abstract][Full Text] [Related]
32. The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.
Silginer M; Burghardt I; Gramatzki D; Bunse L; Leske H; Rushing EJ; Hao N; Platten M; Weller M; Roth P
Oncogene; 2016 Jun; 35(25):3260-71. PubMed ID: 26500056
[TBL] [Abstract][Full Text] [Related]
33. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein.
Kowanetz M; Valcourt U; Bergström R; Heldin CH; Moustakas A
Mol Cell Biol; 2004 May; 24(10):4241-54. PubMed ID: 15121845
[TBL] [Abstract][Full Text] [Related]
34. Snail regulates BMP and TGFβ pathways to control the differentiation status of glioma-initiating cells.
Caja L; Tzavlaki K; Dadras MS; Tan EJ; Hatem G; Maturi NP; Morén A; Wik L; Watanabe Y; Savary K; Kamali-Moghaddan M; Uhrbom L; Heldin CH; Moustakas A
Oncogene; 2018 May; 37(19):2515-2531. PubMed ID: 29449696
[TBL] [Abstract][Full Text] [Related]
35. BMP signaling mediates glioma stem cell quiescence and confers treatment resistance in glioblastoma.
Sachdeva R; Wu M; Johnson K; Kim H; Celebre A; Shahzad U; Graham MS; Kessler JA; Chuang JH; Karamchandani J; Bredel M; Verhaak R; Das S
Sci Rep; 2019 Oct; 9(1):14569. PubMed ID: 31602000
[TBL] [Abstract][Full Text] [Related]
36. Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma.
Lin B; Madan A; Yoon JG; Fang X; Yan X; Kim TK; Hwang D; Hood L; Foltz G
PLoS One; 2010 Apr; 5(4):e10210. PubMed ID: 20419098
[TBL] [Abstract][Full Text] [Related]
37. TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion.
Joseph JV; Conroy S; Tomar T; Eggens-Meijer E; Bhat K; Copray S; Walenkamp AM; Boddeke E; Balasubramanyian V; Wagemakers M; den Dunnen WF; Kruyt FA
Cell Death Dis; 2014 Oct; 5(10):e1443. PubMed ID: 25275602
[TBL] [Abstract][Full Text] [Related]
38. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis.
Myllärniemi M; Lindholm P; Ryynänen MJ; Kliment CR; Salmenkivi K; Keski-Oja J; Kinnula VL; Oury TD; Koli K
Am J Respir Crit Care Med; 2008 Feb; 177(3):321-9. PubMed ID: 17975199
[TBL] [Abstract][Full Text] [Related]
39. Nuclear receptor TLX inhibits TGF-β signaling in glioblastoma.
Johansson E; Zhai Q; Zeng ZJ; Yoshida T; Funa K
Exp Cell Res; 2016 May; 343(2):118-125. PubMed ID: 27048878
[TBL] [Abstract][Full Text] [Related]
40. Neuropilin-1 modulates TGFβ signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy.
Kwiatkowski SC; Guerrero PA; Hirota S; Chen Z; Morales JE; Aghi M; McCarty JH
PLoS One; 2017; 12(9):e0185065. PubMed ID: 28938007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
